GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...

The "Typhoid Fever - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.Comprehensive insights into the future of typhoid fever treatment are now available, exploring ...

Arexvy has been approved in Malaysia for RSV (respiratory syncytial virus), for older adults aged 60 and above. The vaccine ...

Cancer Vaccines Market revenue is expected to hold around USD 24.22 billion by 2033 from USD 9 million in 2023 with a ...

(Alliance News) - GSK PLC on Tuesday announced a new positive opinion from the EU's European Medicine Agency's Committee for Medicinal Products for Human Use. The London-based pharmaceutical company ...

Falak is a newly built Grade A office building located in the heart of Dubai Internet City (DIC), offering over 90,000 square ...

DoctorsOfJoy aims to highlight how dentists empower individuals to fully enjoy life's moments by addressing oral health ...

NewZNew - Sensodyne Celebrates World Dentist Day with #DoctorsOfJoy Campaign: Sensodyne, a leading oral care brand from ...

Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

Investors will look forward to the Nifty hitting psychologically crucial 26,000 mark. Catch the latest on Indian equity ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on GlaxoSmithKline (GB:GSK – Research Report), Sonova Holding AG (CH:SOON – Research Report) and Corbus Pharmaceuticals ...